1. Home
  2. RGEN vs OHI Comparison

RGEN vs OHI Comparison

Compare RGEN & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • OHI
  • Stock Information
  • Founded
  • RGEN 1981
  • OHI 1992
  • Country
  • RGEN United States
  • OHI United States
  • Employees
  • RGEN N/A
  • OHI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • OHI Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • OHI Real Estate
  • Exchange
  • RGEN Nasdaq
  • OHI Nasdaq
  • Market Cap
  • RGEN 7.6B
  • OHI 10.2B
  • IPO Year
  • RGEN N/A
  • OHI N/A
  • Fundamental
  • Price
  • RGEN $158.23
  • OHI $37.56
  • Analyst Decision
  • RGEN Buy
  • OHI Buy
  • Analyst Count
  • RGEN 12
  • OHI 12
  • Target Price
  • RGEN $187.44
  • OHI $38.45
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • OHI 1.9M
  • Earning Date
  • RGEN 02-19-2025
  • OHI 02-05-2025
  • Dividend Yield
  • RGEN N/A
  • OHI 7.19%
  • EPS Growth
  • RGEN N/A
  • OHI 40.81
  • EPS
  • RGEN N/A
  • OHI 1.36
  • Revenue
  • RGEN $633,513,000.00
  • OHI $1,011,391,000.00
  • Revenue This Year
  • RGEN $2.28
  • OHI N/A
  • Revenue Next Year
  • RGEN $9.88
  • OHI $9.06
  • P/E Ratio
  • RGEN N/A
  • OHI $27.39
  • Revenue Growth
  • RGEN N/A
  • OHI 18.25
  • 52 Week Low
  • RGEN $113.50
  • OHI $27.53
  • 52 Week High
  • RGEN $211.13
  • OHI $44.42
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 62.05
  • OHI 44.26
  • Support Level
  • RGEN $150.23
  • OHI $35.94
  • Resistance Level
  • RGEN $160.64
  • OHI $38.16
  • Average True Range (ATR)
  • RGEN 5.93
  • OHI 0.72
  • MACD
  • RGEN 0.96
  • OHI 0.04
  • Stochastic Oscillator
  • RGEN 83.86
  • OHI 65.06

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

Share on Social Networks: